Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,200
Closed -$505K 288
2024
Q3
$505K Buy
6,200
+1,200
+24% +$96K 0.05% 231
2024
Q2
$371K Buy
5,000
+300
+6% +$22.5K 0.1% 155
2024
Q1
$366K Sell
4,700
-2,000
-30% -$149K 0.11% 166
2023
Q4
$479K Sell
6,700
-916
-12% -$63.8K 0.15% 146
2023
Q3
$529K Sell
7,616
-200
-3% -$15.1K 0.19% 132
2023
Q2
$633K Sell
7,816
-600
-7% -$49K 0.22% 118
2023
Q1
$679K Buy
8,416
+516
+7% +$41.5K 0.28% 87
2022
Q4
$591K Buy
7,900
+100
+1% +$7.12K 0.25% 99
2022
Q3
$503K Hold
7,800
0.24% 102
2022
Q2
$541K Buy
7,800
+5,400
+225% +$401K 0.24% 99
2022
Q1
$184K Buy
+2,400
New +$173K 0.07% 162

Other funds holding HOLX

Denali Advisors's HOLX Position: Q4 2024 in Review

Denali Advisors sold out of Hologic (HOLX) in Q4 2024, closing a stake of 6,200 shares — an estimated $505K sold.

Denali Advisors first reported a position in HOLX in Q1 2022 and held it in 11 quarters. The position peaked at $679K in Q1 2023. 718 funds tracked by Wall St. Rank hold HOLX as of Q4 2024.

  • Denali Advisors reported no remaining Hologic position as of Q4 2024 after selling out during the quarter.
  • Denali Advisors sold 6,200 Hologic shares in Q4 2024, an estimated $505K.
  • Denali Advisors first reported a position in Hologic in Q1 2022 and held it in 11 quarters.
  • Denali Advisors's Hologic position peaked at $679K in Q1 2023.
  • 718 funds tracked by Wall St. Rank held Hologic as of Q4 2024.

Based on Denali Advisors's 13F filing for Q4 2024, filed 4 Feb 2025.